BILL & MELINDA GATES FOUNDATION -  

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Number of Projects:> 1000

Ranking timeline:

Project Participation Performance(2020-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2020 0 126.374.786 0 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
COMMISSARIAT A L'ENERGIE ATOMIQUE2
FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSIATRIO LA PAZ2
JANSSEN PHARMACEUTICA NV2
SERVICIO MADRILENO DE SALUD2
UNIVERSITY OF DUNDEE2
ABBVIE INC1
AIBIOPHARMA1
AICURIS ANTIINFECTIVE CURES1
ASTELLAS PHARMA EUROPE BV1
BAYER1
BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE1
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG1
CENTRE D'ETUDE ET DE RECHERCHES VETERINAIRES ET AGROCHIMIQUES1
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS1
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE1
CENTRUM VOOR INNOVATIE EN STIMULATIE VAN MEDICIJNONTWIKKELING LEUVEN VZW1
CONSIGLIO NAZIONALE DELLE RICERCHE1
CRITICAL PATH INSTITUTE LIMITED1
DEPARTMENT OF HEALTH1
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE1
EIDGENOESSISCHES DEPARTEMENT DES INNERN1
ENYO PHARMA1
EUROVACC FOUNDATION1
EVOTEC INTERNATIONAL1
EXSCIENTIA LIMITED1
FONDATION INNOVATIVE MEDICINES FOR TUBERCULOSIS (IM4TB)1
FORSCHUNGSZENTRUM BORSTEL1
FUNDACIO PRIVADA INSTITUT DE RECERCA DE L'HOSPITAL DE LA SANTA CREU I SANT PAU1
GLAXOSMITHKLINE INVESTIGACION Y DESARROLLO SL1
GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT NON PROFIT ORGANISATION1
GLOBAL HEALTH DRUG DISCOVERY INSTITUTE1
GRITSYSTEMS AS1
HELMHOLTZZENTRUM FUR INFEKTIONSFORSCHUNG1
IKTOS1
IMABIOTECH SAS1
INSERM TRANSFERT1
INSTITUT DE RECHERCHES SERVIER1
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE1
INSTITUT PASTEUR1
INSTITUT PASTEUR DE LILLE1
JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT1
KATHOLIEKE UNIVERSITEIT LEUVEN1
KLINIKUM DER UNIVERSITAET ZU KOELN1
LATVIAN INSTITUTE OF ORGANIC SYNTHESIS1
LEIDS UNIVERSITAIR MEDISCH CENTRUM1
LUND UNIVERSITY1
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN1
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE1
NOVARTIS PHARMA1
NUVISAN ICB1
PFIZER LIMITED1
QPS NETHERLANDS BV1
SCIFEON APS1
STIFTUNG TIERAERZTLICHE HOCHSCHULE HANNOVER1
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL1
TAKEDA PHARMACEUTICALS INTERNATIONAL1
THE UNIVERSITY OF EDINBURGH1
UNIVERSIDAD CARLOS III DE MADRID1
UNIVERSIDAD DE ZARAGOZA1
UNIVERSITA DEGLI STUDI DI PADOVA1
UNIVERSITA DEGLI STUDI DI PAVIA1
UNIVERSITAET ZU LUEBECK1
UNIVERSITE D'AIX MARSEILLE1
UNIVERSITE DE BORDEAUX1
UNIVERSITE PARIS XII VAL DE MARNE1
UNIVERSITEIT UTRECHT1
UNIVERSITY OF HAMBURG1
UNIWERSYTET JAGIELLONSKI1
UPPSALA UNIVERSITET1

Constancy:

Total number of partners: 74
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 74
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2020-04-01Corona Accelerated R&D in Europe CAREparticipant36.559.18643
2020-01-01EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS ERA4TBparticipant89.815.60033